MAP2K7 and cardiac hypertrophy: Raf1L613V mice show normal valvuloseptal growth, but exhibit eccentric cardiac hypertrophy, probably due to enhanced MEK-ERK signaling, confirming the relevant role of the RAS-ERK pathway in the pathogenesis of HCM [23].